Rutegård Miriam K, Båtsman Malin, Blomqvist Lennart, Rutegård Martin, Axelsson Jan, Ljuslinder Ingrid, Rutegård Jörgen, Palmqvist Richard, Brännström Fredrik, Brynolfsson Patrik, Riklund Katrine
Department of Radiation Sciences, Diagnostic Radiology, Umeå University, Umeå, Sweden.
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Cancer Imaging. 2020 Oct 31;20(1):80. doi: 10.1186/s40644-020-00347-6.
To enable the evaluation of locoregional disease in the on-going RECTOPET (REctal Cancer Trial on PET/MRI/CT) study; a methodology to match mesorectal imaging findings to histopathology is presented, along with initial observations.
FDG-PET/MRI examinations were performed in twenty-four consecutively included patients with rectal adenocarcinoma. In nine patients, of whom five received neoadjuvant treatment, a postoperative MRI of the surgical specimen was performed. The pathological cut-out was performed according to clinical routine with the addition of photo documentation of each slice of the surgical specimen, meticulously marking the location, size, and type of pathology of each mesorectal finding. This allowed matching individual nodal structures from preoperative MRI, via the specimen MRI, to histopathology.
Preoperative MRI identified 197 mesorectal nodal structures, of which 92 (47%) could be anatomically matched to histopathology. Of the matched nodal structures identified in both MRI and histopathology, 25% were found to be malignant. These malignant structures consisted of lymph nodes (43%), tumour deposits (48%), and extramural venous invasion (9%). One hundred eleven nodal structures (55%) could not be matched anatomically. Of these, 97 (87%) were benign lymph nodes, and 14 (13%) were malignant nodal structures. Five were malignant lymph nodes, and nine were tumour deposits, all of which had a short axis diameter < 5 mm.
We designed a method able to anatomically match and study the characteristics of individual mesorectal nodal structures, enabling further research on the impact of each imaging modality. Initial observations suggest that small malignant nodal structures assessed as lymph nodes in MRI often comprise other forms of mesorectal tumour spread.
Clinical Trials Identifier: NCT03846882 .
为正在进行的RECTOPET(直肠癌PET/MRI/CT试验)研究中的局部区域疾病评估提供支持;本文介绍了一种将直肠系膜成像结果与组织病理学进行匹配的方法以及初步观察结果。
对24例连续纳入的直肠腺癌患者进行了FDG-PET/MRI检查。其中9例患者接受了新辅助治疗,5例术后对手术标本进行了MRI检查。病理切片按照临床常规进行,并对手术标本的每一层进行拍照记录,仔细标记每个直肠系膜发现的病理位置、大小和类型。这使得能够通过标本MRI将术前MRI中的单个淋巴结结构与组织病理学进行匹配。
术前MRI识别出197个直肠系膜淋巴结结构,其中92个(47%)可在解剖学上与组织病理学匹配。在MRI和组织病理学中均识别出的匹配淋巴结结构中,25%被发现为恶性。这些恶性结构包括淋巴结(43%)、肿瘤沉积物(48%)和壁外静脉侵犯(9%)。111个淋巴结结构(55%)在解剖学上无法匹配。其中,97个(87%)为良性淋巴结,14个(13%)为恶性淋巴结结构。5个为恶性淋巴结,9个为肿瘤沉积物,所有这些结构的短轴直径均<5mm。
我们设计了一种方法,能够在解剖学上匹配并研究单个直肠系膜淋巴结结构的特征,从而能够进一步研究每种成像方式的影响。初步观察结果表明,在MRI中被评估为淋巴结的小恶性淋巴结结构通常包含其他形式的直肠系膜肿瘤扩散。
临床试验标识符:NCT03846882 。